Intrathecal opioid treatment for chronic non-malignant pain: A 3-year prospective study

Pain

Volumn 109, Issue 3, 2004, Pages 242-249

  Thimineur, Mark A ^a   Kravitz, Edward ^a   Vodapally, Mohan S ^a  

^a GRIFFIN HOSPITAL   (United States)

Author keywords

Intrathecal; Non malignant; Opioid; Pain; Pump

Indexed keywords

ANTIBIOTIC AGENT; BACLOFEN; BUPIVACAINE; CLONIDINE; DIHYDROMORPHINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE; STEROID;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; EDEMA; HEALTH SURVEY; HUMAN; HYPOGONADISM; INFECTION; LONG TERM CARE; MOOD; MYELITIS; NAUSEA; PAIN; PAIN ASSESSMENT; PATIENT REFERRAL; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUESTIONNAIRE; SEDATION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ACTIVITIES OF DAILY LIVING; ADULT; AFFECT; AGED; ANALGESICS, OPIOID; CHRONIC DISEASE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MIDDLE AGED; PAIN MEASUREMENT; PAIN, INTRACTABLE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 2442473697     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2004.01.003     Document Type: Article

References (11)

1. Anderson V.C., Burchiel K.J. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery. 44:1999;289-300
2. Doleys D.M., Coleton M., Tutak U. Use of intraspinal infusion therapy with non-cancer pain patients: follow up and comparison of workers compensation vs. non-workers compensation patients. Neuromodulation. 1:1998;149-159
3. Kumar K., Kelly M., Pirlo B.A. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg Neurol. 55:2001;79-88
4. Maron J., Loeser J.D. Spinal opioid infusions in the treatment of chronic pain of nonmalignant origin. Clin J Pain. 12:1996;174-179
5. Paice A., Penn R.D., Shott S. Instraspinal morphine for chronic: a retrospective, multicenter study. J Pain Symptom Manage. 11:1996;71-80
6. Plummer JL, Cherry DA, Cousins MK, Gourlay GK, Onley MM, Evans KA. Long-term spinal administration of morphine in cancer and non-cancer pain. A retrospective study. Pain 1991:44;215-20.
7. Portenoy R.K., Savage S.R. Clinical realities and economic considerations: special therapeutic issues in intrathecal therapy - tolerance and addiction. J Pain Symptom Manage. 14:1997;S27-S35
8. Roberts L.J., Finch P.M., Goucke C.R., Price L.M. Outcome of intrathecal opioids in chronic non-cancer pain. Eur J Pain. 5:2001;353-361
9. Schuchard M., Lanning R., North R., Reig E., Krames E. Neurolgic sequela of intraspinal drug delivery systems: results of a survey of American implanters of implantable drug delivery systems. Neuromodulation. 1:1998;137-148
10. Tutak U., Doleys D.M. Intrathecal infusion systems for treatment of chronic low back and leg pain of noncancer origin. South Med J. 89:1996;295-300
11. Winkelmuller M., Winkelmuller W. Long term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg. 85:1996;458-467